DrugCite
Search

TAGAMET HB

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Tagamet Hb Adverse Events Reported to the FDA Over Time

How are Tagamet Hb adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Tagamet Hb, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Tagamet Hb is flagged as the suspect drug causing the adverse event.

Most Common Tagamet Hb Adverse Events Reported to the FDA

What are the most common Tagamet Hb adverse events reported to the FDA?

Drug Ineffective
152 (20.51%)
Diarrhoea
32 (4.32%)
Drug Administration Error
25 (3.37%)
Abdominal Pain Upper
24 (3.24%)
Vomiting
21 (2.83%)
Constipation
17 (2.29%)
Dizziness
17 (2.29%)
Malaise
16 (2.16%)
Nausea
16 (2.16%)
Dyspepsia
15 (2.02%)
Headache
14 (1.89%)
Show More Show More
Somnolence
13 (1.75%)
Urticaria
13 (1.75%)
Faeces Discoloured
10 (1.35%)
Intentional Drug Misuse
9 (1.21%)
Rash
8 (1.08%)
Chest Pain
7 (.94%)
Condition Aggravated
7 (.94%)
Expired Drug Administered
7 (.94%)
Fatigue
7 (.94%)
Hypersensitivity
7 (.94%)
Product Quality Issue
7 (.94%)
Pruritus
7 (.94%)
Abdominal Discomfort
6 (.81%)
Asthenia
6 (.81%)
Blood Pressure Increased
6 (.81%)
Feeling Abnormal
6 (.81%)
Flatulence
6 (.81%)
Insomnia
6 (.81%)
Burning Sensation
5 (.67%)
Chromaturia
5 (.67%)
Drug Exposure During Pregnancy
5 (.67%)
Dry Mouth
5 (.67%)
Abdominal Distension
4 (.54%)
Drug Interaction
4 (.54%)
Dysgeusia
4 (.54%)
Erythema
4 (.54%)
Gastrooesophageal Reflux Disease
4 (.54%)
Muscle Spasms
4 (.54%)
Nervousness
4 (.54%)
Pruritus Generalised
4 (.54%)
Throat Irritation
4 (.54%)
Tremor
4 (.54%)
Back Pain
3 (.4%)
Blood Glucose Increased
3 (.4%)
Cough
3 (.4%)
Eructation
3 (.4%)
Feeling Hot
3 (.4%)
Hypertension
3 (.4%)
Oedema Peripheral
3 (.4%)
Swelling
3 (.4%)
Abdominal Pain
2 (.27%)
Anorexia
2 (.27%)
Aortic Dilatation
2 (.27%)
Balance Disorder
2 (.27%)
Blister
2 (.27%)
Blood Glucose Decreased
2 (.27%)
Cheilitis
2 (.27%)
Coronary Artery Occlusion
2 (.27%)
Drug Toxicity
2 (.27%)
Dyspnoea
2 (.27%)
Feeling Cold
2 (.27%)
Frequent Bowel Movements
2 (.27%)
Heart Rate Increased
2 (.27%)
Hepatic Enzyme Increased
2 (.27%)
Hyperhidrosis
2 (.27%)
Local Swelling
2 (.27%)
Night Sweats
2 (.27%)
Paraesthesia
2 (.27%)
Poor Peripheral Circulation
2 (.27%)
Poor Quality Sleep
2 (.27%)
Postnasal Drip
2 (.27%)
Pyrexia
2 (.27%)
Rash Generalised
2 (.27%)
Rash Macular
2 (.27%)
Skin Exfoliation
2 (.27%)
Therapeutic Response Unexpected
2 (.27%)
Thirst
2 (.27%)
Vertigo
2 (.27%)
Abnormal Dreams
1 (.13%)
Accidental Exposure
1 (.13%)
Activated Partial Thromboplastin Ti...
1 (.13%)
Adverse Reaction
1 (.13%)
Akathisia
1 (.13%)
Alopecia
1 (.13%)
Amphetamines Positive
1 (.13%)
Anaemia
1 (.13%)
Anxiety
1 (.13%)
Asthma
1 (.13%)
Bladder Cancer Recurrent
1 (.13%)
Blood Urine Present
1 (.13%)
Breath Odour
1 (.13%)
Cardiovascular Disorder
1 (.13%)
Chest Discomfort
1 (.13%)
Chills
1 (.13%)
Cold Sweat
1 (.13%)
Completed Suicide
1 (.13%)
Cystitis
1 (.13%)
Decreased Appetite
1 (.13%)
Dehydration
1 (.13%)
Derealisation
1 (.13%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Tagamet Hb, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Tagamet Hb is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Tagamet Hb

What are the most common Tagamet Hb adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Tagamet Hb, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Tagamet Hb is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Tagamet Hb According to Those Reporting Adverse Events

Why are people taking Tagamet Hb, according to those reporting adverse events to the FDA?

Dyspepsia
45
Drug Use For Unknown Indication
24
Gastrooesophageal Reflux Disease
18
Product Used For Unknown Indication
11
Ulcer
6
Flatulence
3
Show More Show More
Gastric Disorder
2
Skin Papilloma
2
Abdominal Pain Upper
2
Antacid Therapy
1
Chest Pain
1
Rash
1
Eczema
1
Routine Health Maintenance
1
Gastritis
1
Hyperchlorhydria
1

Tagamet Hb Case Reports

What Tagamet Hb safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Tagamet Hb. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Tagamet Hb.